S&P 500   3,982.50 (+0.78%)
DOW   32,382.34 (+0.43%)
QQQ   308.69 (+0.89%)
AAPL   158.84 (+0.91%)
MSFT   271.52 (-0.26%)
META   200.50 (+1.36%)
GOOGL   104.82 (+3.56%)
AMZN   99.95 (+2.29%)
TSLA   195.49 (+6.68%)
NVDA   260.29 (+0.50%)
NIO   9.25 (+5.71%)
BABA   83.44 (+3.01%)
AMD   95.53 (-1.32%)
T   18.49 (+0.00%)
F   11.76 (+5.19%)
MU   58.36 (+1.25%)
CGC   1.98 (+6.45%)
GE   92.60 (+2.98%)
DIS   96.39 (+2.30%)
AMC   4.43 (+3.75%)
PFE   40.43 (-0.93%)
PYPL   75.92 (+3.70%)
NFLX   305.67 (+0.18%)
S&P 500   3,982.50 (+0.78%)
DOW   32,382.34 (+0.43%)
QQQ   308.69 (+0.89%)
AAPL   158.84 (+0.91%)
MSFT   271.52 (-0.26%)
META   200.50 (+1.36%)
GOOGL   104.82 (+3.56%)
AMZN   99.95 (+2.29%)
TSLA   195.49 (+6.68%)
NVDA   260.29 (+0.50%)
NIO   9.25 (+5.71%)
BABA   83.44 (+3.01%)
AMD   95.53 (-1.32%)
T   18.49 (+0.00%)
F   11.76 (+5.19%)
MU   58.36 (+1.25%)
CGC   1.98 (+6.45%)
GE   92.60 (+2.98%)
DIS   96.39 (+2.30%)
AMC   4.43 (+3.75%)
PFE   40.43 (-0.93%)
PYPL   75.92 (+3.70%)
NFLX   305.67 (+0.18%)
S&P 500   3,982.50 (+0.78%)
DOW   32,382.34 (+0.43%)
QQQ   308.69 (+0.89%)
AAPL   158.84 (+0.91%)
MSFT   271.52 (-0.26%)
META   200.50 (+1.36%)
GOOGL   104.82 (+3.56%)
AMZN   99.95 (+2.29%)
TSLA   195.49 (+6.68%)
NVDA   260.29 (+0.50%)
NIO   9.25 (+5.71%)
BABA   83.44 (+3.01%)
AMD   95.53 (-1.32%)
T   18.49 (+0.00%)
F   11.76 (+5.19%)
MU   58.36 (+1.25%)
CGC   1.98 (+6.45%)
GE   92.60 (+2.98%)
DIS   96.39 (+2.30%)
AMC   4.43 (+3.75%)
PFE   40.43 (-0.93%)
PYPL   75.92 (+3.70%)
NFLX   305.67 (+0.18%)
S&P 500   3,982.50 (+0.78%)
DOW   32,382.34 (+0.43%)
QQQ   308.69 (+0.89%)
AAPL   158.84 (+0.91%)
MSFT   271.52 (-0.26%)
META   200.50 (+1.36%)
GOOGL   104.82 (+3.56%)
AMZN   99.95 (+2.29%)
TSLA   195.49 (+6.68%)
NVDA   260.29 (+0.50%)
NIO   9.25 (+5.71%)
BABA   83.44 (+3.01%)
AMD   95.53 (-1.32%)
T   18.49 (+0.00%)
F   11.76 (+5.19%)
MU   58.36 (+1.25%)
CGC   1.98 (+6.45%)
GE   92.60 (+2.98%)
DIS   96.39 (+2.30%)
AMC   4.43 (+3.75%)
PFE   40.43 (-0.93%)
PYPL   75.92 (+3.70%)
NFLX   305.67 (+0.18%)
NYSE:INSP

Inspire Medical Systems - INSP Stock Forecast, Price & News

$245.70
-2.38 (-0.96%)
(As of 03/21/2023 01:45 PM ET)
Add
Compare
Today's Range
$245.22
$251.65
50-Day Range
$229.06
$278.01
52-Week Range
$142.74
$282.31
Volume
190,659 shs
Average Volume
308,059 shs
Market Capitalization
$7.14 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$303.00

Inspire Medical Systems MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.83 Rating Score
Upside/​Downside
21.8% Upside
$303.00 Price Target
Short Interest
Healthy
3.55% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.66
Upright™ Environmental Score
News Sentiment
0.71mentions of Inspire Medical Systems in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$11.10 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.32) to ($0.47) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.29 out of 5 stars

Medical Sector

272nd out of 988 stocks

Surgical & Medical Instruments Industry

26th out of 101 stocks


INSP stock logo

About Inspire Medical Systems (NYSE:INSP) Stock

Inspire Medical Systems, Inc. engages in the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. It offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.

Receive INSP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inspire Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

INSP Stock News Headlines

Stocks For Smart Investors
This under-the-radar stock is in the right industry at the perfect time.
Stocks For Smart Investors
This under-the-radar stock is in the right industry at the perfect time.
Inspire Medical Systems Inc (INSP)
Inspire Medical Systems Tops Q4 EPS by 72c
See More Headlines
Receive INSP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inspire Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

INSP Company Calendar

Last Earnings
2/07/2023
Today
3/21/2023
Next Earnings (Estimated)
5/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
485
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$303.00
High Stock Price Forecast
$330.00
Low Stock Price Forecast
$270.00
Forecasted Upside/Downside
+22.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
6 Analysts

Profitability

Net Income
$-44,880,000.00
Pretax Margin
-10.85%

Debt

Sales & Book Value

Annual Sales
$407.86 million
Book Value
$17.17 per share

Miscellaneous

Free Float
27,596,000
Market Cap
$7.21 billion
Optionable
Optionable
Beta
1.47

Key Executives

  • Timothy P. HerbertTimothy P. Herbert
    President, Chief Executive Officer & Director
  • Philip J. Ebeling
    Chief Operating Officer
  • Richard John BuchholzRichard John Buchholz
    Chief Financial Officer
  • John Rondoni
    Chief Technology Officer
  • Bryan K. Phillips
    Secretary, Chief Compliance Officer & Senior VP













INSP Stock - Frequently Asked Questions

Should I buy or sell Inspire Medical Systems stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last year. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" INSP shares.
View INSP analyst ratings
or view top-rated stocks.

What is Inspire Medical Systems' stock price forecast for 2023?

6 equities research analysts have issued 12-month price targets for Inspire Medical Systems' stock. Their INSP share price forecasts range from $270.00 to $330.00. On average, they predict the company's share price to reach $303.00 in the next year. This suggests a possible upside of 22.1% from the stock's current price.
View analysts price targets for INSP
or view top-rated stocks among Wall Street analysts.

How have INSP shares performed in 2023?

Inspire Medical Systems' stock was trading at $251.88 at the start of the year. Since then, INSP stock has decreased by 1.5% and is now trading at $248.08.
View the best growth stocks for 2023 here
.

Are investors shorting Inspire Medical Systems?

Inspire Medical Systems saw a decline in short interest during the month of February. As of February 28th, there was short interest totaling 1,030,000 shares, a decline of 15.6% from the February 13th total of 1,220,000 shares. Based on an average daily volume of 293,100 shares, the short-interest ratio is currently 3.5 days.
View Inspire Medical Systems' Short Interest
.

When is Inspire Medical Systems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 2nd 2023.
View our INSP earnings forecast
.

How were Inspire Medical Systems' earnings last quarter?

Inspire Medical Systems, Inc. (NYSE:INSP) issued its earnings results on Tuesday, February, 7th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.54) by $0.64. The business had revenue of $137.90 million for the quarter, compared to the consensus estimate of $137.75 million. Inspire Medical Systems had a negative net margin of 11.00% and a negative trailing twelve-month return on equity of 12.66%. Inspire Medical Systems's revenue was up 75.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.09) EPS.

What guidance has Inspire Medical Systems issued on next quarter's earnings?

Inspire Medical Systems issued an update on its FY 2023 earnings guidance on Tuesday, February, 7th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $560.00 million-$570.00 million, compared to the consensus revenue estimate of $541.57 million.

What is Tim Herbert's approval rating as Inspire Medical Systems' CEO?

2 employees have rated Inspire Medical Systems Chief Executive Officer Tim Herbert on Glassdoor.com. Tim Herbert has an approval rating of 100% among the company's employees. This puts Tim Herbert in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Inspire Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inspire Medical Systems investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Cisco Systems (CSCO), Bank of America (BAC), DocuSign (DOCU), Pfizer (PFE), Block (SQ), Zynga (ZNGA), CrowdStrike (CRWD) and Johnson & Johnson (JNJ).

When did Inspire Medical Systems IPO?

(INSP) raised $75 million in an initial public offering on Thursday, May 3rd 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs acted as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.

What is Inspire Medical Systems' stock symbol?

Inspire Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "INSP."

Who are Inspire Medical Systems' major shareholders?

Inspire Medical Systems' stock is owned by a number of retail and institutional investors. Top institutional investors include Franklin Resources Inc. (3.72%), Macquarie Group Ltd. (3.65%), William Blair Investment Management LLC (2.88%), Gilder Gagnon Howe & Co. LLC (1.86%), Fred Alger Management LLC (1.77%) and Geode Capital Management LLC (1.75%). Insiders that own company stock include Casey M Tansey, Chau Quang Khuong, Georgia Melenikiotou, Jerry C Griffin, John Rondoni, Marilyn C Nelson, Orbimed Advisors Llc, Philip Ebeling, Randy Ban, Richard Buchholz, Steven Jandrich, Timothy P Herbert and Timothy P Herbert.
View institutional ownership trends
.

How do I buy shares of Inspire Medical Systems?

Shares of INSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Inspire Medical Systems' stock price today?

One share of INSP stock can currently be purchased for approximately $248.08.

How much money does Inspire Medical Systems make?

Inspire Medical Systems (NYSE:INSP) has a market capitalization of $7.21 billion and generates $407.86 million in revenue each year. The company earns $-44,880,000.00 in net income (profit) each year or ($1.64) on an earnings per share basis.

How many employees does Inspire Medical Systems have?

The company employs 485 workers across the globe.

How can I contact Inspire Medical Systems?

Inspire Medical Systems' mailing address is 5500 WAYZATA BLVD SUITE 1600, GOLDEN VALLEY MN, 55416. The official website for the company is www.inspiresleep.com. The company can be reached via phone at (844) 672-4357 or via email at inspire@lifesciadvisors.com.

This page (NYSE:INSP) was last updated on 3/21/2023 by MarketBeat.com Staff